Ignite Creation Date:
2025-12-24 @ 11:53 AM
Ignite Modification Date:
2026-01-25 @ 10:15 PM
Study NCT ID:
NCT02840461
Status:
COMPLETED
Last Update Posted:
2020-06-02
First Post:
2016-07-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Clinical Endpoint Study of Ivermectin 1% Cream
Sponsor:
Actavis Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Moderate to Severe Papulopustular Rosacea | View |
Keywords: